FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

13191201000001101: Co-amoxiclav 250mg/125mg dispersible tablets sugar free (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Oct 2020. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    109658001000001115 Co-amoxiclav 250mg/125mg dispersible tablets sugar free (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    109658101000001119 Co-amoxiclav 250mg/125mg dispersible tablets sugar free en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Is a Product containing amoxicillin and clavulanate potassium false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Has active ingredient Amoxicillin false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Has active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Has specific active ingredient Amoxicillin trihydrate false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Has specific active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg dispersible tablets sugar free Is a Co-amoxiclav false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has VMP False Co-amoxiclav 250mg/125mg dispersible tablets sugar free Inferred relationship Existential restriction modifier
    Augmentin 375mg dispersible tablets (GlaxoSmithKline) Is a False Co-amoxiclav 250mg/125mg dispersible tablets sugar free Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start